Cite
HARVARD Citation
Flohr, C. et al. (2023). Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial. Journal of dermatological treatment. p. . [Online].